A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With Atherosclerotic Cardiovascular Disease
Clinical trial NCT07551492 · RECRUITING
Trial details
- NCT number
- NCT07551492
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-29
- Primary completion
- 2031-05-01
- Enrollment
- 9262
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.